Aurum Biosciences Ltd., Oxygen Biotherapeutics deal

Oxygen disclosed in its 1Q12 earnings ended July 31 that in July it signed a letter of intent with Aurum to conduct preclinical research evaluating Oxygen's Oxycyte perfluorocarbon (PFC)-based therap...